Comprehensive coverage

DNA markers

Dr. Anat Cohen-Dig, CEO of Compugen

Compugen and Mark Sarono's venture capital fund are jointly establishing Neviah Genomics) a new company for the discovery and development of diagnostic markers

  • No comments
Science website logo
SEARCH